Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo

समान संसाधन

• Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
  द्वारा: Puri Raj K, और अन्य
  प्रकाशित: (2011-04-01)
• Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
  द्वारा: Fujisawa, Toshio, और अन्य
  प्रकाशित: (2011)
• A Novel Combination Immunotherapy for Cancer by IL-13Rα2–Targeted DNA Vaccine and Immunotoxin in Murine Tumor Models
  द्वारा: Nakashima, Hideyuki, और अन्य
  प्रकाशित: (2011)
• Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
  द्वारा: Fujisawa, Toshio, और अन्य
  प्रकाशित: (2014)
• Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
  द्वारा: Nakashima, Hideyuki, और अन्य
  प्रकाशित: (2010)